The Department of Biomedical Engineering is honored to host a seminar at 2 p.m. Friday, Nov. 6 via Zoom by Dr. Ed Damiano, research professor of biomedical engineering at Boston University and founder-CEO of Beta Bionics, Inc. and chairman of the board.
Zoom meeting ID: 941 4723 8874. Password: 045408.
Seminar abstract: “Twenty-six years ago, when my infant son was diagnosed with type 1 diabetes, I set my sights on building and integrating autonomous, intelligent systems into a purpose-built, wearable medical device that I referred to as a bionic pancreas. In 2021, a 13-week pivotal clinical trial was conducted that tested the iLet Bionic Pancreas in 440 adults and children with type 1 diabetes. The clinical data from that pivotal trial was published in the New England Journal of Medicine in 2022. Based in part on that data, the iLet Bionic Pancreas received clearance by the US Food and Drug Administration in May 2023. Since June 2023, the iLet has been commercially available for people six years and older with type 1 diabetes through commercial and government insurance across the US. Results from the pivotal clinical trial will be presented and compared with real-world results of the iLet during the first 18 and 24 months of commercial usage.”
